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ABSTRACT 
Objective: The aim of this work was to evaluate the stability of all-in-one (AIO) admixtures exposed to gamma irradiation sterilization.  
Methods: The samples were divided into four groups with 10 bags each: a) Group I: control samples (bags without sterilization or inoculation with 
microorganisms); b) Group II: bags sterilized by gamma irradiation; c) Group III: bags inoculated and then irradiated and, d) Group IV: bags only 
inoculated. The following studies were performed: macroscopic analysis of admixtures; physicochemical stability; degree of lipoperoxidation (LPO), 
and microbiological tests.  
Results: Gamma irradiation sterilization was 100% effective, since no irradiated sample showed growth of microorganisms. All groups exhibited 
similar particle size distribution, but a longer storage time led to a smaller percentage of large particles. In general, irradiated samples showed 
reduced LPO.  
Conclusion: Gamma irradiation sterilization of these admixtures can be extended to clinical practice, as it results in physicochemically stable 
admixtures. 
Keywords: Total parenteral nutrition, Gamma irradiation, Physicochemical stability, Lipid peroxidation, Microbiological analyses. 
 
INTRODUCTION 
The various products used to compound all-in-one (AIO) admixtures 
or Total Parenteral Nutrition (TPN) can interact by various 
mechanisms, some of which are not completely understood. These 
interactions can cause physicochemical instability requiring strict 
control during production and clinical use [1]. 
The most critical property used to determine lipid emulsion 
physicochemical stability is the percentage of particles larger than 5 
µm. This must not exceed a total of 0.05% of lipid globules in 
admixture, according to United States Pharmacopoeia (USP) 
specifications, because lipid globules of this size may cause embolic 
syndrome by obstruction of the pulmonary capillaries, mainly in 
preterm infants [2–4].  
Lipid peroxidation (LPO), which occurs in the presence of reactive 
oxygen species (ROS), is another property that can compromise 
the stability of the admixture [1]. LPO is a process under which 
antioxidants such as free radicals, or nonradical species attack 
lipids, resulting in lipid peroxyl radicals and hydroperoxides, 
which trigger oxidative stress and toxicity. Polyunsaturated fatty 
acids (PUFAs) are more susceptible to lipid peroxidation than 
other fatty acids [5].  
LPO is influenced by the composition of the lipid emulsion, the 
storage conditions (temperature, light), and by the plastic used in 
the manufacture of the infusion bags [1]. The process of LPO can be 
reduced when photo-resistant infusion devices are used and when 
the TPN is protected from light, stored under refrigeration and 
packed into bags impermeable to O2 [6]. 
Multilayered bags are preferable for packaging all-in-one 
admixtures as they protect against the adsorption of oxygen, 
preventing LPO and increasing the stability of the admixture [7]. 
The literature reports that various micro-organisms may grow using 
the nutrients in TPN, for example: Candida albicans, Staphylococcus 
saprophyticus, Escherichia coli, Enterobacter cloacae, Pseudomonas 
aeruginosa, Staphylococcus aureus and Staphylococcus epidermidis. 
What determines which micro-organism will grow is the proportion 
of nutrients in TPN [8]. Species of Enterobacter are important 
nosocomial pathogens. They have been associated with intravenous 
use of contaminated products, due to their ability to grow in 
intravenous solutions. The use of parenteral nutrition is a risk factor 
for Enterobacter infection [9]. 
Gamma irradiation using cobalt-60 has been cited to be an effective 
method of sterilization for TPN admixtures without compromising 
physicochemical stability [10]. In order to confirm this context, the 
present work aimed to evaluate the stability of TPN infusions 
submitted to gamma irradiation through macroscopic analysis of the 
AIO admixtures, analysis of physicochemical parameters of stability 
and quantifying the degree of LPO. The sterility of the irradiated 
admixtures was assessed by microbiological testing of representative 
samples of TPN bags prepared in the northeast of Brazil. 
MATERIALS AND METHODS  
Preparation of samples and experimental groups 
TPN bags (samples: n=40) were prepared according to local 
Guidelines for Good Practice for Preparation of Parenteral Nutrition, 
with standardized formulations, routinely used to supply the 
nutritional needs of adults (table 1). The samples were prepared 
asseptically, in a clean room (controlled environment area with 
filtered air) using a class 100 Horizontal Laminar Flow Cabinet 
(Veco ®) situated in a private institution in Fortaleza, Ceará, Brazil. 
The samples were divided into four groups with 10 bags each: a) 
Group I: control samples (bags without sterilization and without 
inoculation); b) Group II: bags sterilized by gamma irradiation; c) 
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Group III: bags inoculated with microorganisms and then sterilized 
by gamma irradiation and, d) Group IV: bags only inoculated. All 
bags were subjected to a macroscopic observation, including the 
tendency for cream formation and color change. 
From the 10 bags in each group, five were stored under room-
controlled temperature (22 ° to 28 °C) and the others were stored at 
refrigerated controlled temperature (2 ° to 8 °C). All samples were 
analyzed at time zero (T0), 24, 48, 72 and 168 hours (h) after 
preparation. At each time point, 3 ml aliquots were aseptically 
withdrawn from each bag at the specified time to perform each of 
the tests. Physicochemical parameters of stability were quantified 
(mean particle size of lipid droplets and their distribution) as well as 
the degree of LPO. Microbiological tests were conducted to assess 
the sterility of the samples. 
Statistical analysis (ANOVA) was performed using Prism version 5.0, 
with the significance level set at *P<0.05. This study was approved 
by the Ethics Committee of the Federal University of Ceará (Process 
number 142/07). 
 
Table 1: Composition of standardized bags for adult patients 
Components Quantity 
Standard Amino Acids Solution* 50.0 g 
Glucose Solution 50% 125.0 g 
Lipid Emulsion MCT/LCT 20%** 50.0 g 
Sodium Chloride Solution 20% 34.0 mEq 
Potassium Chloride Solution 10% 33.0 mEq 
Magnesium Sulfate Solution 50% 5.0 mEq 
Calcium Gluconate Solution 10% 5.0 mEq 
Potassium Phosphate Solution 2 mEq/ml 5.0 mEq 
Trace Elements*** 1.0 ml 
Vitamin C1 5.0 ml 
B-Complex Vitamins2 4.0 ml 
Total Volume 1058.3 ml 
Source: Formulations of parenteral nutrition standard for adults, 
adapted [11] 
 
*Polyaminoacid Solution 10% (w/v), composition (100 ml): L-
isoleucine 5.00 mg; L-leucine 7.40 mg; L-lysine 6.60 mg eq. A L-
lysine 9.31 mg; L-methionine 4.30 mg; L-fenilanine 5.10 mg; L-
trionine 4.40 mg; L-tryptophan 2.00 mg; L-valine 6.20 mg; L-
arginine 12.0 mg; L-histidine 3.00 mg; glicine 14.0 mg; L-alanine 
15.0 mg; L-proline 15.0 mg; glacial acetic acid 8.01 mg; sodium 
hydroxide; water for injection; Aminoacid total 100 g/l; Nitrogen 
total 16.4 g/l. **Lipid emulsion 20%, Composition (100 ml): Long-
chain triglycerides (soya oil) 10.0 g; medium-chain triglycerides 10.0 
g; egg lecithin 1.20 g; glycerol 2.50 g; water for injection. ***Trace 
elements solution for adult use, composition (1 ml): zinc 2.5 mg 
(zinc sulphate 7H2O); copper 0.8 mg (copper sulphate 5H2O); 
manganese 0.4 mg (manganese sulphate H2O); chrome 10 µg (chome 
chloride 6H2O); water for injection. 1Composition (5 ml): vitamin C 
500 mg; vehicle (sodium bisulphite, sodium hydroxide, water for 
injection); 2Composition (2 ml): thiamine chloride (B1) 8 mg, 
riboflavin (B2) 2 mg, pyridoxine chloride (B6) 4 mg, nicotinamide 
(PP) 40 mg, D-pantenol (pro-vitamin B5) 6 mg, vehicle (sodium 
chloride, phenol, water for injection). 
Inoculation of samples 
Before the gamma irradiation (in case of Group III), samples from 
Group III and IV were inoculated with microorganisms at time zero 
(T0). The microorganism used in the experiment (Enterobacter 
cloacae) was incubated in BHI broth (Brain Heart Infusion) at 35–37 
°C for 24 h. Bacterial suspensions were then prepared in saline 
0.85% to obtain moderate turbidity visibly equivalent to 0.5 on the 
McFarland scale which equates to a concentration of about 108 
CFU/ml. Subsequently, decimal serial dilutions were prepared using 
9 ml of saline solution to each 1 ml of the previous dilution [12] to 
give final concentrations of 108, 107, 106, 105 and 104 CFU/ml. 
The bags of TPN were then inoculated, using aseptic technique, with 
1 ml of each concentration. Following homogenization of the 
admixture, 3 ml aliquots were immediately withdrawn for analysis 
(the others aliquots withdrawn in subsequent steps and tests were 
also 3 ml). That point, after inoculation, was considered as time zero 
(T0). The other counts were made at times: 24, 48, 72 and 168 h. 
Irradiation of samples 
Only the samples from Groups II and III were individually sterilized 
by gamma radiation, using a Gamma Irradiator (source Cobalt-60), 
model Gamma Cell® 220 Excel from MDS Nordion, and a radiation 
dose of 1.5 kGy. The Department of Nuclear Energy of Federal 
University of Pernambuco made this equipment available for our 
study.  
Before irradiating the 20 bags from Groups II and III, aliquots were 
withdrawn to perform the analysis at time zero (T0). At the same time, 
aliquots were withdrawn from the other 20 bags (Groups I and IV). 
Throughout the period in which the samples from Groups II and III 
were being transported and irradiated, the other samples from 
Groups I and IV remained under the same conditions (refrigerated 
controlled temperature: 2 ° to 8 °C).  
After the irradiation process, half of samples from all groups were 
stored at room-controlled temperature (22 ° to 28 °C) and the other 
half was stored under refrigerated controlled temperature (2 ° to 8 
°C). Subsequently, aliquots were withdrawn from all bags for 
analysis at each time point: time zero (T0), 24, 48, 72 and 168 h, as 
described by Sforzini and colleagues [13] and Antunes [14]. All 
samples were stored protected from light throughout [15]. 
Analysis of samples 
Physicochemical stability tests 
The tests to evaluate physicochemical stability were performed in 
duplicate at all time intervals (T0 and 24 to 168 h), using a particle 
analyzer model Zetasizer Nano® series Nano ZS® of Malvern 
Instruments Ltd. This equipment is able to measure the 
characteristics of particles in liquid environments, within a range of 
particle size varying from 0.4 nm to 10 μm. The device determines 
particle size and distribution through a process called Dynamic Light 
Scattering (DLS), also known as Photon Correlation Spectroscopy 
(PCS), which measures Brownian Motion (particulate dispersion 
movement), linking it to the size of the particles [16, 17]. 
At each time interval an aliquot was withdrawn from each bag. Then, 
into a cuvette with 1 ml of distilled water, one drop of this sample 
was added (just enough to make the solution slightly turbid 
according to MALVERN INSTRUMENTS LTD [18]). Then, the cuvette 
was put into the device for examination. 
Tests of lipoperoxidation  
The degree of LPO of the sample was measured using the dosage of 
thiobarbituric acid reactive substances-TBARS assay, according to 
the method described by Agar [19]. Tests were performed in 
duplicate at all time intervals. Aliquots were withdrawn aseptically 
from each bag and 250 µl of this aliquot was added to an Eppendorf 
reagent reservoir in a water-bath at 37 °C for 1 h. Then, 400 µl of 
perchloric acid 35% was added and centrifuged for 20 min at 14 000 
RPM. Next, 200 µl of thiobarbituric acid 1.2% was added to the 
Eppendorf in a water-bath at 90-100 °C for 30 min. Finally, the 
reservoir was cooled in an ice bath prior to reading at 532 nm in a 
spectrophotometer. 
Microbiological tests 
The analysis to count viable microorganisms used the method of 
depth spreading or plating (per plate) [12]. The procedure, in 
duplicate, was performed at each time interval of the study: T0 
(inoculation), 24, 48, 72 and 168 h. 
A 3 ml aliquot was withdrawn from each bag, but only 1 ml was 
added to a sterile Eppendorf. Then, Triton X-100 10% was added to 
facilitate homogenization of the sample with the growth medium. 
The homogenate was added to an empty sterile plate (90x15 mm). 
The growth medium (Agar Plate Count) in liquid form at about 40–
45 °C, was poured into the plate sufficient to cover the base (12–15 
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ml) with light rotational movements for homogenization. The plates 
were incubated for 48 h in a bacteriological stove regulated at 35–37 °C. 
After 48 h of incubation, the colonies, which grew both on the 
surface of agar and into the agar, were counted using an electronic 
colony meter. The result was expressed in CFU/ml. 
RESULTS 
Macroscopic properties 
Formation of cream 
Cream formation was more apparent in samples stored at room-
controlled temperature (22 ° to 28 °C). In these samples a cream was 
observed, due to accumulation of triglyceride particles on the 
surface of the formulation, giving the appearance white regions on 
the admixtures’ surface.  
The formation of cream occurred gradually over time, and was 
initially found 72 h after preparation. In the irradiated samples 
(Groups II and III), cream formation was much less apparent at both 
storage temperatures and was noticed only at the end of the study. 
Cream formation was also noticed in bags that were not irradiated 
and kept under refrigeration. 
Change of color 
The irradiated samples stored at room temperature and 
refrigeration (Groups II and III) did not show any change in color 
from T0 until the end of the study. Similarly, the bags stored under 
refrigeration (2 ° to 8 °C) without irradiation (Groups I and IV), also 
showed no color change from T0 up until the end of the study period 
(168 h). Only the bags stored under room temperature of Groups I 
and IV showed color change, gradually during the analysis time.  
Physicochemical stability test 
The particle size ranged from 37.8 nm to 5560 µm for all groups 
investigated. The average size was in the range 255–395 nm, 
corresponding to 11.78–15.14% of volume distribution. After 24 h of 
sample preparation, it appears that molecule rearrangements occur, 
leading to a narrower volume distribution, with a smaller average 
particle size. This behavior was exhibited by all sample groups, 
independent of storage temperature or irradiation status (fig. 1). It 
should be noted that all groups exhibited similar particle size 
distribution, for particle size larger than 5 µm, at room and 
refrigerated temperatures, whereas longer storage time leads to a 
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Fig. 1: Size and lipid particle distributions for samples of Groups I-IV, at room-and refrigerated controlled temperature, at different 
storage times a, a1: Group I–control samples (bags without sterilization and without inoculation); b, b1: Group II-bags sterilized by 
gamma irradiation; c, c1: Group III-bags inoculated with microorganisms and then sterilized by gamma irradiation; d, d1: Group IV-bags 
only inoculated. Left side: room temperature; Right side: refrigerated temperature 
 
 
Fig. 2: Lipid size distribution for particles larger than 5 µm of all 
Groups, at room temperature 
Group I–control samples (bags without sterilization and 
without inoculation); Group II-bags sterilized by gamma 
irradiation; Group III-bags inoculated with microorganisms and 
then sterilized by gamma irradiation; Group IV-bags only 
inoculated 
 
Lipoperoxidation stability test 
The levels of LPO remained higher in the bags stored at room-
controlled temperature (22 ° to 28 °C) (fig. 3) than in those under 
refrigerated temperature (2 ° to 8 °C) (fig. 4) (*P<0.05). The lowest 
levels of LPO occurred in the irradiated samples with even a 
reduction in LPO at some time intervals compared with the 
respective controls (Group I). 
 
 
Fig. 3: Variation in percentage of TBARS (thiobarbituric acid 
reactive substances) in samples under room-controlled 
temperature (22 ° to 28 °C) Group I–control samples (bags 
without sterilization and without inoculation); Group II-bags 
sterilized by gamma irradiation; Group III-bags inoculated with 
microorganisms and then sterilized by gamma irradiation; 
Group IV-bags only inoculated 
 
Fig. 4: Variation in percentage of TBARS (thiobarbituric acid 
reactive substances) in samples under refrigerated controlled 
temperature (2 ° to 8 °C) Group I–control samples (bags without 
sterilization and without inoculation); Group II-bags sterilized 
by gamma irradiation; Group III-bags inoculated with 
microorganisms and then sterilized by gamma irradiation; 
Group IV-bags only inoculated 
 
Microbiological test 
Samples of Group I (control samples) showed growth of 
microorganisms 168 hours after preparation. The samples stored 
under room-controlled temperature showed more microbial growth. 
Samples of Group II (irradiated only) showed no growth of 
microorganisms during the study period. Samples of Group III 
(samples inoculated and irradiated) showed growth of 
microorganisms only in the analyses performed at T0 (after the 
inoculation of microorganisms); after sterilization by gamma 
radiation there was no further growth. Group IV (samples only 
inoculated) showed growth of microorganisms at all time intervals. 
It was also observed that the quantity of microorganisms decreased 
over time. 
DISCUSSION 
In relation to macroscopic properties of the samples, the first visible 
sign of change was the formation of cream, a dense layer on the 
surface of the AIO admixture. A cream layer is a normal alteration of 
this pharmaceutical formulation. Some studies report that the 
formation of cream can occur without significant change in the lipid 
particle size, and the AIO admixture can be administered if the lipid 
is dispersed by light homogenization, since AIO admixtures are 
generally safe for patient administration, because it is a reversible 
condition [1, 6, 20, 21].  
Our samples at room-controlled temperature showed more 
pronounced cream formation, similar to that reported in other 
studies [22-24]. In fact, according to Driscoll et al. [22] admixtures 
made with only LCT-based lipid emulsion (long chain triglycerides) 
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showed visible signs of instability after only 30 h at room 
temperature. Lobo and colleagues [23] found a cream layer 
formation from 48 h. In addition, Ribeiro et al. obtained results that 
ranged from 48 to 72 h at room temperature, depending on the 
amount of calcium in the formulation [24].  
Free oil formed as a result of phase separation. Driscoll and 
colleagues [22] also reported that admixtures composed with the 
MCT/LCT-based lipid emulsion (medium chain and long chain 
triglycerides), remained stable for long, which also occurred in our 
study, since the first signs of cream formation were observed at 72 h 
after the admixture preparation. Furthermore, the results obtained 
by other studies at refrigerated controlled temperatures [23-25] 
reported creaming formation at similar times those observed in our 
study.  
Driscoll and colleagues [22] also identified that for every 10 °C 
increase in temperature, there was a two–three fold increase in the 
degradation rate of lipid emulsions in AIO admixtures. Therefore, a 
difference of about 20 °C between the refrigerated and the room 
temperature is significant to cause destabilization. However, storage 
under refrigeration only prolongs the inevitable process of 
destabilization, which is a characteristic of the AIO admixture. 
Admixtures containing a MCT/LCT-based lipid emulsion are easier 
to homogenize because the size of the triglyceride chain is reduced 
and the interfacial tension between the oil and water phases is 
lowered conferring better admixture stability. 
The irradiated samples showed an almost imperceptible formation 
of cream, which occurred later in the study in samples stored at both 
temperatures when compared to non-irradiated admixtures. A study 
of Du Plessis & Rosekilly [10] of gamma irradiation sterilization 
applied to AIO admixtures reported similar results, in which neither 
formation of cream nor phase separation was observed in the 
irradiated admixtures, even in samples irradiated at doses above 8.3 
kGy. Irradiation did not affect the physical stability of the lipid 
component in AIO admixtures. 
The change of color occurred in the non-irradiated admixtures 
stored under room-controlled temperature. This is an undesirable 
change, because it can be a cause for loss of some nutrients. The 
color alteration may be due to Maillard’s reaction, also known as 
non-enzymatic browning, which is due to a series of chemical 
reactions involving amino acids and carbohydrates such as glucose. 
Several factors such as high temperatures, exposure to light and 
time of contact between the components of the admixture, favor 
non-enzymatic browning [6, 26, 27]. 
In our work, all bags containing the admixtures were protected from 
light (light is another factor that may cause color alteration of the 
admixture [24]), except at the time when the aliquots were 
withdrawn for the tests. On the other hand, some bags were stored 
under room-temperature, where the time of contact between the 
components of the admixture at higher temperatures is relatively 
long. Such samples suffered Maillard’s reaction, thus explaining the 
color change. 
The change of color may also be due to the degradation of some 
vitamins added to AIO admixtures, especially vitamin C, which 
changes color to yellow or brown due to hydrolysis, and the B 
complex vitamins, especially vitamin B1, which changes color due to 
the formation of thiochrome [6, 26]. Although studies that correlate 
gamma radiation use and the color change in AIO admixtures were 
not found, our results suggest that the use of gamma radiation 
preserves the color, which may indicate conservation of vitamins 
and nutrients which can undergo Maillard’s reaction.  
In relation to physicochemical stability, the average size of lipid 
particles (255–395 nm) are in agreement with USP 31<729>, which 
indicates that the mean droplet diameter size obtained by light 
scattering methods must be less than 500 nm for lipid injectable 
emulsions [3, 28].  
Lipid particles>5 μm were present in all groups at time zero. 
Samples of Group I, stored in room temperature, showed the highest 
percentage of lipid particles>5 μm, reaching 1.18% in the samples 
analyzed at 24 h. In bags stored under refrigeration, the percentage 
of lipid particles>5 μm reached 0.78%, also within 24 h. The same 
occurred in samples from Group IV. Similar results were observed 
by Driscoll et al. [29], who found the percentage of lipid particles>5 
μm higher than 0.4% between 6 and 24 h after preparing the 
admixture. However, Lobo et al. [23] did not observe any 
formulation with percentage of lipid particles>5 μm, at refrigerated 
temperature and at room temperature, for all storage times.  
Although administration of TPN occurs within 24 h of preparation, 
such admixtures are already unsuitable for use. In other studies, 
Driscoll [17, 29] reported that admixtures containing lipid 
particles>5 μm, at a percentage higher than 0.4% of total fat, become 
unstable and are unfit for human administration. Lipid particles 
higher than 5 μm may clog the lung capillaries, which can cause 
embolism and other complications including death [3, 30].  
Studies by Driscoll & Lobo [22, 23, 31] reported a reduction in the 
percentage of lipid particles>5 μm over time, which the authors 
attributed mainly to extensive damage (separation of phases) of 
lipid emulsion, resulting in a migration of larger particles to the 
surface of the admixture, making it non-homogeneous. In these same 
studies, the authors concluded that destabilization of emulsions 
occurs at some point between 8 and 24 h after preparation and that 
in all lipid emulsions, lipid particles>5 μm were found at all time 
intervals. 
In Groups I and IV, a gradual reduction in the percentage of lipid 
particles>5 μm over time was also observed, reaching zero at 168 h 
for the samples of Group I stored at room-controlled temperature.  
The samples of Groups II and III also showed lipid particles>5 μm 
just after preparation (T0). However, in the analysis performed after 
irradiation, lipid particles>5 μm were no longer found. This occurred 
in the samples stored in room temperature and in the refrigerated 
samples.  
Du Plessis & Rosekilly [10] found similar results. No sample 
contained lipid particles>5 μm after irradiation, even when higher 
doses, up to 8.3 kGy, were applied. Our study used a dose of 1.5 kGy. 
This result suggests that the gamma irradiation sterilization makes 
the AIO admixtures safer regarding the risk of embolism.  
In the LPO studies, the control samples stored at both temperatures 
showed a gradual increase in TBARS over time, being less 
pronounced in the refrigerated samples. When samples from all 
groups were compared, it was observed that levels of LPO remained 
higher in the bags stored in room-controlled temperature (22 ° to 28 
°C) than in those under controlled refrigeration (2 ° to 8 °C). Steger 
& Mühlebach [15] report that an increase in storage temperature 
results in a significant increase in LPO of AIO admixtures and that 
each 10 °C increase in temperature results in an incremental 
increase in LPO. 
Sobotka [1] and Picaud et al. [32] reported exposure to light 
significantly increase LPO. Sobotka also stated that use of 
multilayered bags (less permeable to oxygen), protection from light 
and storage under refrigeration, reduces the infusion of peroxides to 
patients. In the present study, the samples were protected from light 
and packaged into multilayered bags.  
In our work, the irradiated samples generally showed a reduction in 
TBARS. No reports of the occurrence of LPO related to gamma 
radiation sterilization of admixtures were found. However, a study 
of Badr [33] reports that gamma irradiation, at a dose of 3 kGy, had 
no significant effects on the fatty acid profile of lipids from egg yolk, 
and that irradiation, at room temperature, followed by storage at 
refrigeration (4 °C±1 °C), seems to be a suitable treatment for egg 
white and yolk. The author also reports that irradiation of egg yolk 
caused an increase in the content of free fatty acids, increasing the 
LPO component of the egg yolk, but such increase was relatively low 
and within acceptable standards. 
Tükenmez et al. [34] found that gamma irradiation applied in the 
presence of oxygen accelerates the self-oxidation of lipids in fish, 
and the presence of oxygen greatly influences the apparent value of 
oxidation produced, but that this may be linked to the properties of 
the food and the conditions of processing, such as the radiation dose 
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applied, temperature and packaging. Kfouri Filho & Akamine [3] 
mentioned that high temperatures increase the activation energy of 
the molecules, and the degradation reactions (oxidation and 
hydrolysis) are more likely to occur at higher temperatures. 
In the samples that were inoculated only, stored at 22 ° to 28 °C, 
there was an increase in the TBARS 24 h immediately after 
preparation, but after inoculation there was a reduction, which 
remained until 72 h, followed by a considerable increase at 168 h. In 
refrigerated samples there was an increase in TBARS up to 48 h, 
followed by a reduction at 72 h and then another increase at 168 h. 
After inoculation, the microorganisms possibly inactivated the 
peroxides, due to their catalase-positive characteristic, which is 
peculiar to Enterobacter cloacae [35]. With time, the supply of food 
for the microorganisms is exhausted, causing their death and 
allowing a further an increase in LPO reflected by an increase in 
TBARS at the end of the study. 
In the samples only irradiated, microorganisms did not grow in any 
analysis. The same occurred in the samples inoculated and 
irradiated, in which even bags with the highest inoculums (108 
CFU/ml), gamma irradiation was effective in destroying all the 
microorganisms. 
A study mentioned that Enterobacter cloacae is sensitive to radiation 
at a dose of only 0.40 kGy [10]. It also reports that even with the 
highest concentration of microorganisms inoculated (7.6 x 104 
CFU/ml) in admixture, and the lowest dose of irradiation applied 
(1.5 kGy), no microorganisms were detected, indicating the 
effectiveness of the gamma irradiation in sterilizing AIO admixtures. 
In Group IV, microorganisms grew in all samples, since these 
admixtures were inoculated with microorganisms, and were not 
irradiated. However, over time, the counts of these microorganisms 
decreased, which may have occurred due to both a shortage of food 
and pH reduction caused by an increase in LPO over time [36]. 
Sobotka [1] describes that a low pH of around 5.5 prevents the 
growth of microorganisms in AIO admixtures. 
CONCLUSION 
Gamma radiation sterilization at a dose of 1.5 kGy, applied to AIO 
admixtures was 100% effective, since no irradiated sample showed 
growth of microorganisms, even with the highest inoculum of 
bacteria, suggesting that this dose seems sufficient to sterilize the 
samples. 
As irradiated admixtures demonstrated physicochemical stability 
(obtaining good results with respect to creaming, color change and 
particle size), there is potential for their use in clinical practice. 
Further studies are required to confirm these findings.  
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